Nanosonics
Dr. McIntyre joined the Nanosonics Board in November 2019. Her executive background is in strategy, particularly in the areas of medical technology and healthcare, with many years as a partner at L.E.K. Consulting in the US and Australia where she led the Asia Pacific Health practice. Dr. McIntyre was a Director of the Garvan Institute of Medical Research for 12 years and is a Senate Fellow of the University of Sydney and on the advisory committee of the NSW Generations Fund. She is currently a Non-executive Director of HCF Group, Insurance for NSW (icare), and Studiosity Pty Ltd.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Nanosonics
Nanosonics Ltd is an Australia-based company focused on developing automated disinfection technology. The Company's principal activities include manufacturing and distribution of the trophon ultrasound probe disinfector and its associated consumables and accessories and research, development and commercialization of infection control and decontamination products and related technologies. The Company's automated Trophon electron paramagnetic resonance (EPR) disinfection device provides solutions for care in ultrasound probe disinfection practices. trophon is its solution for reducing cross contamination between patients and reducing the spread of Healthcare Acquired Infections (HAIs). Its trophon2 product includes AcuTrace technology, which enables digital record keeping and provides workflows for ultrasound probe high level disinfection. Its consumable and accessories include NanoNebulant, trophon Chemical Indicator, trophon AcuTrace Operator Card and trophon Printer.